An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A. Soucy, Steven Langston, Rachel E. Gershman et al.|Nature|2009Cited by 2k
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In SituJames E. Brownell, Lawrence R. Dick, Michael D. Sintchak et al.|Molecular Cell|2010Cited by 461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L. Hyer, Neil Bence, Michael A. Milhollen et al.|Nature Medicine|2018Cited by 453
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphomaMichael A. Milhollen, Peter G. Smith, Tary Traore et al.|Blood|2010Cited by 323
NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer CellsJie Lin, Anindya Dutta, Michael A. Milhollen et al.|Cancer Research|2010Cited by 293